Investment Q&A

Q: WHAT IS YOUR OPINION ABOUT THIS UPCOMING COMPANY. BNGO

Q: Please give me your opinion and analysis of DNA . Would you recommend this stock for a 2 to 3 year purchase. Cathy Wood has been an early investor and continues to buy stock now. Thanks

Q: Greetings 5i team.

Can you please give me your updated opinion on THNK?
I don't see any results for 8/23. When do they report next?
What are the numbers expected?
Do you think the recent Chartwell win will move the needle much on revenue?
I like the space they are occupying in the transition telemedicine going forward. Do you?

Many thanks.

Q: Hello team,

Is it worth holding on to this biotechnology company?

Have been holding for a long time and down 75%. Don't need the money but wondering if averaging down will be a good idea, given their cash level?

Any updates since last news and the halting of their phase 3 trial in August?

Thanks as always! :)

Q: I own Abbvie already and would like to add another company from the health care sector. What would be your next choice for a long term hold in a dividend focused portfolio? Considering maybe JNJ, PFE, BMY, AMGN, ABT, MRK.

Q: Skylight Health Group Inc (TSXV:SLHG).

Stock is coming down for a while. what is the reason? Is it good time to buy?

Q: Hello, I would be interested in DVAX as a hold, thanks

Q: I am considering selling Veev or Abbv and buying Syk or Mdt. Could I have your thoughts on these companies today and which ones have the most long term promise? Would you have other suggestions in US healthcare?

Q: X Div date on SIS is 9/28, If I buy tomorrow,Sep 27,do I get the Div. Txs for u usual great services & views

Q: Could you please list in order of preference your top 5 Pot Stock Selections & why.
Thanks Richard

Q: Is there a reason the share price of GUD responded so strongly to this news?
"Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America"

Is this the first agreement between GUD and Incyte?

Thanks!

Q: Hi 5i Team,

How would the fact that Humira will be coming off patent in the not too distant future affect share price of Abbv going forward? Is it a buy, sell or hold now?
Cheers,
H

Q: Now that Knight is no longer part of the BEPORT is 5i looking at a sector replacement and if so what is it? If not, since we are not restricted by borders, should we look to the U.S. for a sector weight?

Q: What’s your prognosis for this company? Is there any value in holding any longer? I am massively down on this stock…looks like it’s going to zero. Is there any value here?

Q: good morning - sentiment seems to be trending against my largest US health care position ABBV. Do you think it prudent to sell and reinvest in another company such as Pfizer or another company? Taxes are not an issue. Thanks

Q: Good morning 👀 👀 👀 👀 👀

How significant do you feel the after hour news for ABCL is? Would you buy or add on it? Any thoughts on it's relationship with Moderna and the ongoing potential of the company in general is much appreciated?

thanks, M

Q: You guys are the masters of understatement. Better use? No kidding. LOL.

"We think the cash could be put to better use and will be selling the full position as we begin to re-position the portfolio for next year."


Sheldon

Q: Skylight Health Group recent ongoing acquisitions and overall company performance .... would you comment on buying at this price ..thx

Q: Couple days back there was a question regarding VPT. It was stated that there was inside buying, you did not answer how much buying took place. Also, in your answer I was left with the impression that VPT, makes medical equipment, but when I was listening to Robert Mcwhirter, on BNN, I was left with impression that VPT had software that they were going to adopt to GE ultra-sound equipment. So, if you could explain this discrepancy between these two scenario, I would greatly appreciate it. If it turns out that VPT makes medical equipment, what other companies are in this same space.

Question #2 - I bought HNU is the $16.00 range, and now it is up In the $22.00 range. Do you feel it has run its course or is there more upside in the near future. I guess the question would be is it a hold or sell.

Q: I've held VEEV for a while and it seems to be stalled. Time to move on? If yes, would you recommend shifting the funds to bring ATZ up to 4%? Alternatively, is there another company in the health sector you would recommend in VEEV's stead? Medium-risk investor.

Thank you.